Sulfadoxine

规格

2447-57-6CAS 号

219-504-9EC 号

4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamideIUPAC 名称

C12H14N4O4S化学式

310.33 g/mol分子量

SULFADOXINE; 2447-57-6; Sulphadoxine; Sulfadoxin; Sulforthomidine; 4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide; Sulphormethoxine; Sulfadoxinum; Sulfadoxina; Fanzil; Ro 4-4393; Benzenesulfonamide, 4-amino-N-(5,6-dimethoxy-4-pyrimidinyl)-; Fanasulf; 4-Sulfanilamido-5,6-dimethoxypyrimidine; DTXSID6023608; N'-(5,6-Dimethoxy-4-pyrimidyl)sulfanilamide; Ro-4-4393; NSC-759319; Sulformethoxine; Sulformetoxine; WR-4073; CHEBI:9329; 4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzene-1-sulfonamide; J21.373J; Ro-44393; 88463U4SM5; DTXCID703608; Sulphormetoxin; Sulphorthodimethoxine; Sulforthamidine; Ro 44393; Ro 4 4393; RefChem:389293; 219-504-9; Fanasil; 4-Amino-N-(5,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide; C12H14N4O4S; 6-(4-Aminobenzenesulfonamido)-4,5-dimethoxypyrimidine; Sulfadoxine (Sulphadoxine); MFCD00792890; Orthosulfin; Solfadossina; NCGC00016612-01; CAS-2447-57-6; Solfadossina [DCIT]; Sulfadoxinum [INN-Latin]; Sulfadoxina [INN-Spanish]; WR 4873; 1173021-35-6; SR-05000001523; EINECS 219-504-9; N1-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide; BRN 0625453; Sufadoxine; Sulfadoxine (JAN/USP/INN); Sulfadoxine CRS; UNII-88463U4SM5; Sanasil: Sulfadoxine: Sulformetoxin; N(sup 1)-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide; WR 4073; Sulfadoxine [USAN:USP:INN:BAN:JAN]; Sulfadoxine (Standard); SULFADOXINE [MI]; Prestwick0_001094; Prestwick1_001094; Prestwick2_001094; Prestwick3_001094; SULFADOXINE [INN]; SULFADOXINE [JAN]; SULFADOXINE [USAN]; Epitope ID:952452; SULFADOXINE [VANDF]; CHEMBL1539; SULFADOXINE [MART.]; SCHEMBL41069; BSPBio_001168; SULFADOXINE [USP-RS]; SULFADOXINE [WHO-DD]; SULFADOXINE [WHO-IP]; 5-25-13-00306 (Beilstein Handbook Reference); MLS002154150; SPBio_003054; BPBio1_001286; orb1310248; Sulfadoxin, >=95% (TLC); SCHEMBL29390814; GTPL10173; HY-B0439R; MSK4006; SULFADOXINE [ORANGE BOOK]; HMS1571K10; HMS2090P07; HMS2094C19; HMS2098K10; HMS2230E05; HMS3371I15; HMS3715K10; HMS5081O15; Pharmakon1600-01506086; SULFADOXINE [EP MONOGRAPH]; SULFADOXINE [USP MONOGRAPH]; 4-amino-N-[5,6-bis(methyloxy)pyrimidin-4-yl]benzenesulfonamide; HY-B0439; SULFADOXINUM [WHO-IP LATIN]; Tox21_110523; BBL023187; EBC-03788; FANSIDAR COMPONENT SULFADOXINE; MSK4006-100M; NSC759319; s2511; STL356042; AKOS015897281; MSK4006-1000M; Tox21_110523_1; AC-8428; AS01376; CCG-213610; DB01299; KS-5334; NSC 759319; NCGC00016612-02; NCGC00016612-04; NCGC00016612-05; SMR000857259; SY045794; SBI-0206941.P001; DB-046463; Sulfadoxin 1000 microg/mL in Acetonitrile; AB00514044; N1-5,6-Dimethoxy-4-pyrimidinylsulfanilamide; NS00008538; Sulfadoxine Solution in Methanol, 100ug/mL; Sulfadoxine Solution in Methanol, 1000ug/mL; C07630; D00580; EN300-118712; H10765; Sulfadoxin, VETRANAL(TM), analytical standard; AB00514044-06; AB00514044_07; AB00514044_08; Q411557; SR-05000001523-1; SR-05000001523-3; BRD-K55250441-001-03-1; BRD-K55250441-001-06-4; BRD-K55250441-001-12-2; BRD-K55250441-001-13-0; Sulfadoxin, certified reference material, TraceCERT(R); Z1515385080; Sulfadoxine, European Pharmacopoeia (EP) Reference Standard; Sulfadoxine, United States Pharmacopeia (USP) Reference Standard同义词